Empagliflozin in Heart Failure with a Preserved Ejection Fraction. Reply
- PMID: 35613034
- DOI: 10.1056/NEJMc2118470
Empagliflozin in Heart Failure with a Preserved Ejection Fraction. Reply
Comment on
-
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.N Engl J Med. 2022 May 26;386(21):e57. doi: 10.1056/NEJMc2118470. N Engl J Med. 2022. PMID: 35613030 No abstract available.
-
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.N Engl J Med. 2022 May 26;386(21):e57. doi: 10.1056/NEJMc2118470. N Engl J Med. 2022. PMID: 35613031 No abstract available.
-
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.N Engl J Med. 2022 May 26;386(21):e57. doi: 10.1056/NEJMc2118470. N Engl J Med. 2022. PMID: 35613032 No abstract available.
-
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.N Engl J Med. 2022 May 26;386(21):e57. doi: 10.1056/NEJMc2118470. N Engl J Med. 2022. PMID: 35613033 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical